社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
TeslaMoon
IP属地:未知
+关注
帖子 · 44
帖子 · 44
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
TeslaMoon
TeslaMoon
·
2021-12-03
DIS dipped pretty hard recently though? Trend reversal now?
非常抱歉,此主贴已删除
看
3,212
回复
评论
点赞
2
编组 21备份 2
分享
举报
TeslaMoon
TeslaMoon
·
2021-12-02
100% agree, fire sale now
非常抱歉,此主贴已删除
看
3,196
回复
评论
点赞
6
编组 21备份 2
分享
举报
TeslaMoon
TeslaMoon
·
2021-11-18
Transparency is a good move
非常抱歉,此主贴已删除
看
2,270
回复
2
点赞
3
编组 21备份 2
分享
举报
TeslaMoon
TeslaMoon
·
2021-11-18
Hopefully PFE moves up
非常抱歉,此主贴已删除
看
2,878
回复
评论
点赞
1
编组 21备份 2
分享
举报
TeslaMoon
TeslaMoon
·
2021-11-14
About time for it to fly
Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.
Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo
Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.
看
3,177
回复
3
点赞
4
编组 21备份 2
分享
举报
TeslaMoon
TeslaMoon
·
2021-11-11
And it's back down, crypto flash crash
非常抱歉,此主贴已删除
看
3,493
回复
1
点赞
2
编组 21备份 2
分享
举报
TeslaMoon
TeslaMoon
·
2021-11-05
PLTR is going to be big soon, buy at discount now
非常抱歉,此主贴已删除
看
3,410
回复
评论
点赞
4
编组 21备份 2
分享
举报
TeslaMoon
TeslaMoon
·
2021-11-04
This is the future
Elon Musk's Personal Wealth Now Greater Than GM, Ford And These 3 Other Auto Companies Combined
The personal wealth of Elon Musk continues to soar at a record pace with shares of Tesla trading hig
Elon Musk's Personal Wealth Now Greater Than GM, Ford And These 3 Other Auto Companies Combined
看
3,043
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
TeslaMoon
TeslaMoon
·
2021-11-02
Imagine her fund without them, would it have been a loss? 🤔
Cathie Wood’s ARK Innovation Fund Gained 10% in October. Thank Tesla and Coinbase.
The $21.4 billion ARK Innovation exchange-traded fund (ticker: ARKK), managed by outspoken stock pic
Cathie Wood’s ARK Innovation Fund Gained 10% in October. Thank Tesla and Coinbase.
看
2,615
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
TeslaMoon
TeslaMoon
·
2021-11-02
The EV game is won through infrastructure
非常抱歉,此主贴已删除
看
2,062
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
暂无粉丝
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3586118615772335","uuid":"3586118615772335","gmtCreate":1623024591115,"gmtModify":1628043336786,"name":"TeslaMoon","pinyin":"teslamoon","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/d68757b4b03a327ba62e5c6ba27af9dc","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":11,"headSize":10,"tweetSize":44,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.11","exceedPercentage":"80.12%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.03","exceedPercentage":"80.59%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":601103149,"gmtCreate":1638495328884,"gmtModify":1638495329620,"author":{"id":"3586118615772335","authorId":"3586118615772335","name":"TeslaMoon","avatar":"https://static.tigerbbs.com/d68757b4b03a327ba62e5c6ba27af9dc","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586118615772335","authorIdStr":"3586118615772335"},"themes":[],"htmlText":"DIS dipped pretty hard recently though? Trend reversal now?","listText":"DIS dipped pretty hard recently though? Trend reversal now?","text":"DIS dipped pretty hard recently though? Trend reversal now?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601103149","repostId":"2188512561","repostType":4,"isVote":1,"tweetType":1,"viewCount":3212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603891337,"gmtCreate":1638392608177,"gmtModify":1638392608375,"author":{"id":"3586118615772335","authorId":"3586118615772335","name":"TeslaMoon","avatar":"https://static.tigerbbs.com/d68757b4b03a327ba62e5c6ba27af9dc","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586118615772335","authorIdStr":"3586118615772335"},"themes":[],"htmlText":"100% agree, fire sale now","listText":"100% agree, fire sale now","text":"100% agree, fire sale now","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603891337","repostId":"2188556434","repostType":2,"isVote":1,"tweetType":1,"viewCount":3196,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876023688,"gmtCreate":1637245993345,"gmtModify":1637245993345,"author":{"id":"3586118615772335","authorId":"3586118615772335","name":"TeslaMoon","avatar":"https://static.tigerbbs.com/d68757b4b03a327ba62e5c6ba27af9dc","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586118615772335","authorIdStr":"3586118615772335"},"themes":[],"htmlText":"Transparency is a good move","listText":"Transparency is a good move","text":"Transparency is a good move","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/876023688","repostId":"2184602028","repostType":2,"isVote":1,"tweetType":1,"viewCount":2270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876029156,"gmtCreate":1637245957719,"gmtModify":1637245957782,"author":{"id":"3586118615772335","authorId":"3586118615772335","name":"TeslaMoon","avatar":"https://static.tigerbbs.com/d68757b4b03a327ba62e5c6ba27af9dc","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586118615772335","authorIdStr":"3586118615772335"},"themes":[],"htmlText":"Hopefully PFE moves up","listText":"Hopefully PFE moves up","text":"Hopefully PFE moves up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876029156","repostId":"2184689348","repostType":2,"isVote":1,"tweetType":1,"viewCount":2878,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873994111,"gmtCreate":1636819714220,"gmtModify":1636819714324,"author":{"id":"3586118615772335","authorId":"3586118615772335","name":"TeslaMoon","avatar":"https://static.tigerbbs.com/d68757b4b03a327ba62e5c6ba27af9dc","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586118615772335","authorIdStr":"3586118615772335"},"themes":[],"htmlText":"About time for it to fly","listText":"About time for it to fly","text":"About time for it to fly","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/873994111","repostId":"1102251183","repostType":4,"repost":{"id":"1102251183","kind":"news","pubTimestamp":1636772424,"share":"https://www.laohu8.com/m/news/1102251183?lang=&edition=full","pubTime":"2021-11-13 11:00","market":"us","language":"en","title":"Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1102251183","media":"Barrons","summary":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Mo","content":"<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.</p>\n<p>“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.</p>\n<p>Two years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.</p>\n<p>Bourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.</p>\n<p>In a cover story in November 2019, <i>Barron’s</i> argued that Bourla and Dolsten could pull it off.</p>\n<p>The new antiviral data reaffirms the case for Pfizer that <i>Barron’s</i> made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.</p>\n<p>Pfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).</p>\n<p>The Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.</p>\n<p>The worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.</p>\n<p>The success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.</p>\n<p>While Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.</p>\n<p>In the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.</p>\n<p>The antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.</p>\n<p>“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.</p>\n<p>Dolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.</p>\n<p>“[Pfizer’s] pharmaceutical R&D is better than people had thought.”</p>\n<p>The protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.</p>\n<p>“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.</p>\n<p>Pfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).</p>\n<p>“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.</p>\n<p>Chen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.</p>\n<p>“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”</p>\n<p>That makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.</p>\n<p>Biden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”</p>\n<p>Moderna shares are down more than 40% over the past three months.</p>\n<p>As the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling <i>Barron’s</i> that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.</p>\n<p>When it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.</p>\n<p>That contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.</p>\n<p>Dolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”</p>\n<p>Such a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.</p>\n<p>An aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Shows Its R&D Is Strong. It’s a Good Sign for the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-13 11:00 GMT+8 <a href=https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that...</p>\n\n<a href=\"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/buy-pfizer-stock-covid-19-51636674652?mod=hp_LEAD_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102251183","content_text":"Pfizer’s chief scientific officer, Mikael Dolsten, sounded giddy when reached via telephone early Monday morning. It was just days after his company knocked the socks off the market with the news that its Covid-19 antiviral had cut the risk of hospitalization by 89% in high-risk adults.\n“It can’t be just a random thing, that you’re able to beat this type of world record and get a grand slam at the same time by chance,” Dolsten said, scrambling sports metaphors as he sought to illustrate the magnitude of Pfizer’s twin wins: the development of a stunningly effective Covid-19 vaccine in just 10 months, followed a year later by the development of a similarly stunning Covid-19 antiviral.\nTwo years ago, Pfizer (ticker: PFE) CEO Albert Bourla asked investors to take a big gamble on the research-and-development operation that Dolsten has rebuilt over the course of more than a decade. That bet is looking smarter than ever.\nBourla has gotten rid of Pfizer’s off-patent drugs division and the last of its consumer health products, leaving behind a pure-play biopharma company that will live or die on the strength of Dolsten’s science.\nIn a cover story in November 2019, Barron’s argued that Bourla and Dolsten could pull it off.\nThe new antiviral data reaffirms the case for Pfizer that Barron’s made two years ago. Continuing to profit off the pandemic, however, brings new risks, as criticism grows over the global inequity in vaccine distribution. Low-income nations account for less than 1% of the more than seven billion doses administered worldwide. If distribution of Pfizer’s antiviral continues to favor wealthy nations, the company’s stock could ultimately suffer.\nPfizer’s shares surged 10.9% the day the data came out, their best daily showing in at least 20 years. Still, with the stock now changing hands at around $50, investors continue to undervalue the company. Investors are pricing Pfizer at 12 times next year’s expected earnings, cheaper than peers like Johnson & Johnson (JNJ) and Eli Lilly (LLY).\nThe Pfizer discount can be attributed to concerns over the patent cliff the drugmaker faces at the end of the decade. The company stands to lose exclusivity over a handful of drugs that bring in billions in annual revenue.\nThe worries are legitimate, but Pfizer’s scientific coup should give investors confidence that the company’s science can carry it safely over that cliff. It may take time for the market to catch up, but for long-term investors, it’s a promising opportunity.\nThe success of the antiviral is the best illustration yet of Pfizer’s scientific prowess.\nWhile Pfizer’s Covid-19 vaccine came out of the labs of the German biotech BioNTech (BNTX), the new Covid-19 antiviral was whipped up by what Dolsten called a “dream team” of scientists at Pfizer’s own labs across the Northeast U.S.\nIn the earliest days of the pandemic, Pfizer split its efforts between its collaboration with BioNTech on the vaccine and its quest for a Covid-19 pill. The vaccine effort operated on a huge scale; Dolsten called it a “mega team” that spanned the Atlantic.\nThe antiviral project was a much smaller operation—a group of Pfizer experts operating with resources left over from the vaccine push.\n“The small molecule was more like a nimble, laser-focused, high-end team, with rather moderate resources,” Dolsten said.\nDolsten gathered some of Pfizer’s most experienced scientists to work on the antiviral project, including its head of medicine design, Charlotte Allerton. The scientists started with work Pfizer had done years ago on a type of antiviral called a protease inhibitor.\n“[Pfizer’s] pharmaceutical R&D is better than people had thought.”\nThe protease inhibitors in the Pfizer library, however, had been administered intravenously, and had not worked well when delivered orally. The team had to figure out how to adapt the drugs to oral administration, a substantial undertaking.\n“They had to really create a lot of new chemistry,” Dolsten said. The scientists created 600 compounds to nail down the right drug, a process that might normally take years, and which they accomplished in a matter of months. “Four years turned into four months here,” he said.\nPfizer started testing the pill in humans in March. It is now running a number of Phase 2/3 trials of the drug, including one for patients who are high risk, one for patients not high risk, and one as a prophylaxis for patients who have been exposed to the virus but aren’t yet sick. In the first readout, the drug looked substantially more effective than the Covid treatment pill from Merck (MRK).\n“It definitely helps prove the point that [Pfizer’s] pharmaceutical R&D is better than people had thought,” says Louise Chen, an analyst at Cantor Fitzgerald, who has an Overweight rating and a $61 price target on the stock.\nChen says that she doesn’t expect investors to come around to her way of thinking until there is more clarity on the durability of Covid-19 vaccine and pill sales, and the rest of the pipeline gets proved out.\n“There is not one event that I think will trigger a re-rating of the stock at the next level,” she says. “Until those things play out, I don’t think that it necessarily will.”\nThat makes a bet on Pfizer a long-term play. In the meantime, the experience of Moderna (MRNA) in recent weeks is highlighting the potential for the vaccine makers to come under scrutiny over unequal distribution of vaccines.\nBiden administration officials have been increasingly frustrated with Moderna, calling on the company to ramp up production so it can offer more doses at not-for-profit prices to low-income countries, with one top official calling on the company to “step up.”\nModerna shares are down more than 40% over the past three months.\nAs the pandemic persists, Pfizer risks eroding the enormous goodwill it earned roughly a year ago when it introduced its Covid-19 vaccine. Earlier this month, Pfizer CEO Bourla blamed low-income countries for unfair vaccine distribution, telling Barron’s that it was their fault for not placing orders. Pfizer has sold a billion vaccine doses to the U.S. at a not-for-profit price to donate to poor countries, and says that a total of at least two billion doses will be delivered to low- and middle-income nations by the end of next year.\nWhen it comes to antivirals, Pfizer has said only that it will offer tiered pricing for poorer nations, the same approach it has taken with its vaccine.\nThat contrasts sharply with Merck’s plan to make its own Covid-19 pill available to poor countries. Merck has signed a deal with a United Nations-backed group that will allow its pill to be licensed globally, with no royalties paid to Merck.\nDolsten said that Pfizer is looking into licensing its pill under a similar mechanism as Merck’s. “We will look at those options,” he said. “By no means have we said we would do something different. We just want to make sure whoever will be involved gets the advice and skill to do this.”\nSuch a step couldn’t come soon enough. Late last month, activists protested outside Bourla’s home, calling on Pfizer to share its vaccine manufacturing technology and to fill orders from low-income countries ahead of those from wealthy countries.\nAn aggressive plan to share its antiviral would help stave off such criticism, keeping Pfizer in the relative good graces of Washington and allowing its impressive science to continue to drive the stock higher.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":3177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870941275,"gmtCreate":1636584477170,"gmtModify":1636596269747,"author":{"id":"3586118615772335","authorId":"3586118615772335","name":"TeslaMoon","avatar":"https://static.tigerbbs.com/d68757b4b03a327ba62e5c6ba27af9dc","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586118615772335","authorIdStr":"3586118615772335"},"themes":[],"htmlText":"And it's back down, crypto flash crash","listText":"And it's back down, crypto flash crash","text":"And it's back down, crypto flash crash","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/870941275","repostId":"1140564396","repostType":4,"isVote":1,"tweetType":1,"viewCount":3493,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846257439,"gmtCreate":1636089490468,"gmtModify":1636089490649,"author":{"id":"3586118615772335","authorId":"3586118615772335","name":"TeslaMoon","avatar":"https://static.tigerbbs.com/d68757b4b03a327ba62e5c6ba27af9dc","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586118615772335","authorIdStr":"3586118615772335"},"themes":[],"htmlText":"PLTR is going to be big soon, buy at discount now","listText":"PLTR is going to be big soon, buy at discount now","text":"PLTR is going to be big soon, buy at discount now","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/846257439","repostId":"1127581182","repostType":2,"isVote":1,"tweetType":1,"viewCount":3410,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848617552,"gmtCreate":1635994410574,"gmtModify":1636001492705,"author":{"id":"3586118615772335","authorId":"3586118615772335","name":"TeslaMoon","avatar":"https://static.tigerbbs.com/d68757b4b03a327ba62e5c6ba27af9dc","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586118615772335","authorIdStr":"3586118615772335"},"themes":[],"htmlText":"This is the future","listText":"This is the future","text":"This is the future","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848617552","repostId":"1111192471","repostType":2,"repost":{"id":"1111192471","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1635942266,"share":"https://www.laohu8.com/m/news/1111192471?lang=&edition=full","pubTime":"2021-11-03 20:24","market":"us","language":"en","title":"Elon Musk's Personal Wealth Now Greater Than GM, Ford And These 3 Other Auto Companies Combined","url":"https://stock-news.laohu8.com/highlight/detail?id=1111192471","media":"Benzinga","summary":"The personal wealth of Elon Musk continues to soar at a record pace with shares of Tesla trading hig","content":"<p>The personal wealth of <b>Elon Musk</b> continues to soar at a record pace with shares of <b>Tesla</b> trading higher year-to-date. As Musk soars past the rest of the top 10 on the Bloomberg Billionaires Index, he’s also passing the valuation of several Tesla competitors.</p>\n<p><b>What Happened:</b>With Tesla having a valuation of $1.19 trillion, Musk has seen his personal wealth hit $335 billion.</p>\n<p>Musk has added $165 billion to his personal wealth in 2021, according to Bloomberg, thanks to the rising value of Tesla and a $100-billion valuation given to his space company SpaceX earlier this year.</p>\n<p>In late 2020, it was revealed that the valuation of Tesla had passed the value of many of the leading automakers combined. The news highlighted the trending shift to electric vehicles and the rising valuation of electric vehicle companies while the valuations of traditional automakers decline.</p>\n<p>As Musk’s wealth rises, he is now worth more than several automotive companies combined.</p>\n<p><b>Musk Worth More Than Several Tesla Competitors:</b>Musk is worth $335 billion as of Nov. 1 according to Bloomberg.</p>\n<p>With this sizable wealth, Musk is well ahead of <b>Jeff Bezos.</b>The founder of <b>Amazon.com Inc</b> ranks second with a wealth of $193 billion. Muskcould buyevery MLB, NBA, NFL and NHL hockey team and still have money left over.</p>\n<p>The Tesla CEO is also now worth more than <b>Ford Motor Company</b>,<b>General Motors Company</b>,<b>Stellantis</b>,<b>Honda Motor Co</b> and <b>Bayerische Motoren Werke AG</b> combined.</p>\n<p>The market caps are $71 billion, $80 billion, $64 billion, $53 billion and $66 billion, respectively, for a total of $334 billion, just under Musk’s total of $335 billion.</p>\n<p>Musk being worth more than Ford, General Motors and Steallantis, which owns Chrysler, is significant, as they are Detroit's \"Big Three\" in the automotive industry and for years led the way before foreign car companies and electric vehicles started taking away market share.</p>\n<p><b>TSLA Price Action:</b> Shares were down 3.03% at $1,172 at the close Tuesday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk's Personal Wealth Now Greater Than GM, Ford And These 3 Other Auto Companies Combined</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk's Personal Wealth Now Greater Than GM, Ford And These 3 Other Auto Companies Combined\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-11-03 20:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>The personal wealth of <b>Elon Musk</b> continues to soar at a record pace with shares of <b>Tesla</b> trading higher year-to-date. As Musk soars past the rest of the top 10 on the Bloomberg Billionaires Index, he’s also passing the valuation of several Tesla competitors.</p>\n<p><b>What Happened:</b>With Tesla having a valuation of $1.19 trillion, Musk has seen his personal wealth hit $335 billion.</p>\n<p>Musk has added $165 billion to his personal wealth in 2021, according to Bloomberg, thanks to the rising value of Tesla and a $100-billion valuation given to his space company SpaceX earlier this year.</p>\n<p>In late 2020, it was revealed that the valuation of Tesla had passed the value of many of the leading automakers combined. The news highlighted the trending shift to electric vehicles and the rising valuation of electric vehicle companies while the valuations of traditional automakers decline.</p>\n<p>As Musk’s wealth rises, he is now worth more than several automotive companies combined.</p>\n<p><b>Musk Worth More Than Several Tesla Competitors:</b>Musk is worth $335 billion as of Nov. 1 according to Bloomberg.</p>\n<p>With this sizable wealth, Musk is well ahead of <b>Jeff Bezos.</b>The founder of <b>Amazon.com Inc</b> ranks second with a wealth of $193 billion. Muskcould buyevery MLB, NBA, NFL and NHL hockey team and still have money left over.</p>\n<p>The Tesla CEO is also now worth more than <b>Ford Motor Company</b>,<b>General Motors Company</b>,<b>Stellantis</b>,<b>Honda Motor Co</b> and <b>Bayerische Motoren Werke AG</b> combined.</p>\n<p>The market caps are $71 billion, $80 billion, $64 billion, $53 billion and $66 billion, respectively, for a total of $334 billion, just under Musk’s total of $335 billion.</p>\n<p>Musk being worth more than Ford, General Motors and Steallantis, which owns Chrysler, is significant, as they are Detroit's \"Big Three\" in the automotive industry and for years led the way before foreign car companies and electric vehicles started taking away market share.</p>\n<p><b>TSLA Price Action:</b> Shares were down 3.03% at $1,172 at the close Tuesday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111192471","content_text":"The personal wealth of Elon Musk continues to soar at a record pace with shares of Tesla trading higher year-to-date. As Musk soars past the rest of the top 10 on the Bloomberg Billionaires Index, he’s also passing the valuation of several Tesla competitors.\nWhat Happened:With Tesla having a valuation of $1.19 trillion, Musk has seen his personal wealth hit $335 billion.\nMusk has added $165 billion to his personal wealth in 2021, according to Bloomberg, thanks to the rising value of Tesla and a $100-billion valuation given to his space company SpaceX earlier this year.\nIn late 2020, it was revealed that the valuation of Tesla had passed the value of many of the leading automakers combined. The news highlighted the trending shift to electric vehicles and the rising valuation of electric vehicle companies while the valuations of traditional automakers decline.\nAs Musk’s wealth rises, he is now worth more than several automotive companies combined.\nMusk Worth More Than Several Tesla Competitors:Musk is worth $335 billion as of Nov. 1 according to Bloomberg.\nWith this sizable wealth, Musk is well ahead of Jeff Bezos.The founder of Amazon.com Inc ranks second with a wealth of $193 billion. Muskcould buyevery MLB, NBA, NFL and NHL hockey team and still have money left over.\nThe Tesla CEO is also now worth more than Ford Motor Company,General Motors Company,Stellantis,Honda Motor Co and Bayerische Motoren Werke AG combined.\nThe market caps are $71 billion, $80 billion, $64 billion, $53 billion and $66 billion, respectively, for a total of $334 billion, just under Musk’s total of $335 billion.\nMusk being worth more than Ford, General Motors and Steallantis, which owns Chrysler, is significant, as they are Detroit's \"Big Three\" in the automotive industry and for years led the way before foreign car companies and electric vehicles started taking away market share.\nTSLA Price Action: Shares were down 3.03% at $1,172 at the close Tuesday.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":3043,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843432064,"gmtCreate":1635848526760,"gmtModify":1635848526760,"author":{"id":"3586118615772335","authorId":"3586118615772335","name":"TeslaMoon","avatar":"https://static.tigerbbs.com/d68757b4b03a327ba62e5c6ba27af9dc","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586118615772335","authorIdStr":"3586118615772335"},"themes":[],"htmlText":"Imagine her fund without them, would it have been a loss? 🤔","listText":"Imagine her fund without them, would it have been a loss? 🤔","text":"Imagine her fund without them, would it have been a loss? 🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843432064","repostId":"1110664769","repostType":2,"repost":{"id":"1110664769","kind":"news","pubTimestamp":1635836127,"share":"https://www.laohu8.com/m/news/1110664769?lang=&edition=full","pubTime":"2021-11-02 14:55","market":"us","language":"en","title":"Cathie Wood’s ARK Innovation Fund Gained 10% in October. Thank Tesla and Coinbase.","url":"https://stock-news.laohu8.com/highlight/detail?id=1110664769","media":"Barrons","summary":"The $21.4 billion ARK Innovation exchange-traded fund (ticker: ARKK), managed by outspoken stock pic","content":"<p>The $21.4 billion ARK Innovation exchange-traded fund (ticker: ARKK), managed by outspoken stock picker Cathie Wood, gained 10% in October, marking its best monthly return since June. The fund jumped another 3% on the first day of November, continuing the strong momentum from last month.</p>\n<p>Tesla (TSLA), ARK Innovation’s top holding with more than 11% weight, contributed the most to the fund’s gains. The stock in the electric carmaker soared 44% in October, lifting the ARK fund by 4 percentage points alone. Cryptocurrency exchange Coinbase Global (COIN), currently making up nearly 7% of ARK Innovation’s portfolio, also drove the fund’s gains after rising more than 40% in October.</p>\n<p>Other major contributors include digital healthcare leader Teladoc Health (TDOC), music-streaming platform Spotify Technology (SPOT), and videogame software developer Unity Software (U).</p>\n<p>Tesla stock’s latest gains, which made Tesla the sixth company in U.S. history to be worth more than $1 trillion, came after Hertz Global Holdings (HTZZ) ordered 100,000 of its electric vehicles for the rental car company’s fleet. Other members of the trillion-dollar club include Apple (AAPL),Microsoft (MSFT), Google parent Alphabet (GOOGL), and Amazon.com (AMZN).</p>\n<p>Coinbase shares have been rising, on the other hand, as U.S. regulators recently greenlighted two Bitcoin-linked ETFs for the first time, a move that allows the digital asset to delve deeper into brokerage accounts and signals the crypto market going mainstream. Coinbase would benefit from a broad shift toward Bitcoin and other cryptocurrencies, which are integrating into the payment system used by millions of Americans.</p>\n<p>Besides ARK Innovation, all other actively managed funds from Wood’s ARK Invest also finished the month with gains. The $5.5 billion ARK Next Generation Internet ETF (ARKW) rose the most, by 13%, while the $7.2 billion ARK Genomic Revolution ETF (ARKG) saw the smallest increase of 0.6%.</p>\n<p>The ARK Innovation ETF,along with other ARK funds, were some of the best-performing funds in 2020 as the Covid-19 pandemic led to significant gains in the innovation-driven stocks in their portfolios. A few of the ARK funds returned more than 100% last year and attracted billions of dollars in new assets from fervent followers of Wood, an unwavered believer in a future redefined by disruptive innovations and the exponential growth they’ll bring.</p>\n<p>The ARK funds have been struggling to maintain their momentum this year, however. Many of their stockholdings are trading at lofty valuations that are betting on huge expected growth in the future. As inflation flares up and interest rates rise, the current value of these growth companies’ future cash flow is being diminished.</p>\n<p>After peaking in February, the ARK funds have since declined and have traded range bound throughout the year. The latest rebound came in June, when ARK Innovation jumped 17% in that month, but the fund has since been pulling back again. Even after October’s gains, the fund is still largely flat for the year.</p>\n<p>ARK Innovation is now trading around $125 per share, heading toward the ceiling of $131 it’s approached multiple times since February. If the fund can break above that level, it would mark a major bullish turn for the growth and innovation stocks.</p>\n<p>Most of ARK’s other funds have performed better this year, with the $2.6 billion ARK Autonomous Technology & Robotics ETF (ARKQ) leading the pack, up by 11% in the first 10 months of the year.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood’s ARK Innovation Fund Gained 10% in October. Thank Tesla and Coinbase.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood’s ARK Innovation Fund Gained 10% in October. Thank Tesla and Coinbase.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-02 14:55 GMT+8 <a href=https://www.barrons.com/articles/cathie-woods-ark-innovation-fund-gained-10-in-october-thank-tesla-and-coinbase-51635797002?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The $21.4 billion ARK Innovation exchange-traded fund (ticker: ARKK), managed by outspoken stock picker Cathie Wood, gained 10% in October, marking its best monthly return since June. The fund jumped ...</p>\n\n<a href=\"https://www.barrons.com/articles/cathie-woods-ark-innovation-fund-gained-10-in-october-thank-tesla-and-coinbase-51635797002?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKK":"ARK Innovation ETF","TSLA":"特斯拉","COIN":"Coinbase Global, Inc."},"source_url":"https://www.barrons.com/articles/cathie-woods-ark-innovation-fund-gained-10-in-october-thank-tesla-and-coinbase-51635797002?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110664769","content_text":"The $21.4 billion ARK Innovation exchange-traded fund (ticker: ARKK), managed by outspoken stock picker Cathie Wood, gained 10% in October, marking its best monthly return since June. The fund jumped another 3% on the first day of November, continuing the strong momentum from last month.\nTesla (TSLA), ARK Innovation’s top holding with more than 11% weight, contributed the most to the fund’s gains. The stock in the electric carmaker soared 44% in October, lifting the ARK fund by 4 percentage points alone. Cryptocurrency exchange Coinbase Global (COIN), currently making up nearly 7% of ARK Innovation’s portfolio, also drove the fund’s gains after rising more than 40% in October.\nOther major contributors include digital healthcare leader Teladoc Health (TDOC), music-streaming platform Spotify Technology (SPOT), and videogame software developer Unity Software (U).\nTesla stock’s latest gains, which made Tesla the sixth company in U.S. history to be worth more than $1 trillion, came after Hertz Global Holdings (HTZZ) ordered 100,000 of its electric vehicles for the rental car company’s fleet. Other members of the trillion-dollar club include Apple (AAPL),Microsoft (MSFT), Google parent Alphabet (GOOGL), and Amazon.com (AMZN).\nCoinbase shares have been rising, on the other hand, as U.S. regulators recently greenlighted two Bitcoin-linked ETFs for the first time, a move that allows the digital asset to delve deeper into brokerage accounts and signals the crypto market going mainstream. Coinbase would benefit from a broad shift toward Bitcoin and other cryptocurrencies, which are integrating into the payment system used by millions of Americans.\nBesides ARK Innovation, all other actively managed funds from Wood’s ARK Invest also finished the month with gains. The $5.5 billion ARK Next Generation Internet ETF (ARKW) rose the most, by 13%, while the $7.2 billion ARK Genomic Revolution ETF (ARKG) saw the smallest increase of 0.6%.\nThe ARK Innovation ETF,along with other ARK funds, were some of the best-performing funds in 2020 as the Covid-19 pandemic led to significant gains in the innovation-driven stocks in their portfolios. A few of the ARK funds returned more than 100% last year and attracted billions of dollars in new assets from fervent followers of Wood, an unwavered believer in a future redefined by disruptive innovations and the exponential growth they’ll bring.\nThe ARK funds have been struggling to maintain their momentum this year, however. Many of their stockholdings are trading at lofty valuations that are betting on huge expected growth in the future. As inflation flares up and interest rates rise, the current value of these growth companies’ future cash flow is being diminished.\nAfter peaking in February, the ARK funds have since declined and have traded range bound throughout the year. The latest rebound came in June, when ARK Innovation jumped 17% in that month, but the fund has since been pulling back again. Even after October’s gains, the fund is still largely flat for the year.\nARK Innovation is now trading around $125 per share, heading toward the ceiling of $131 it’s approached multiple times since February. If the fund can break above that level, it would mark a major bullish turn for the growth and innovation stocks.\nMost of ARK’s other funds have performed better this year, with the $2.6 billion ARK Autonomous Technology & Robotics ETF (ARKQ) leading the pack, up by 11% in the first 10 months of the year.","news_type":1,"symbols_score_info":{"ARKK":0.9,"COIN":0.9,"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":2615,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":843436518,"gmtCreate":1635848496340,"gmtModify":1635848496340,"author":{"id":"3586118615772335","authorId":"3586118615772335","name":"TeslaMoon","avatar":"https://static.tigerbbs.com/d68757b4b03a327ba62e5c6ba27af9dc","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3586118615772335","authorIdStr":"3586118615772335"},"themes":[],"htmlText":"The EV game is won through infrastructure","listText":"The EV game is won through infrastructure","text":"The EV game is won through infrastructure","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/843436518","repostId":"2180206519","repostType":2,"isVote":1,"tweetType":1,"viewCount":2062,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}